Back to results
US 11,884,691 B2Granted
Functionalized n-acetylgalactosamine analogs
AssigneeHongene Biotech Corporation
InventorsWing C. Poon, Gang Zhao, Gengyu Du, Yun-Chiao Yao, Mufa Zou, Xiaoyang Guan, Xiaoling Zheng, David Yu, Ruiming Zou, Aldrich N. K. Lau
Life of this patent
Estimating the term…
Abstract
Embodiments of the present application relate to functionalized N-acetylgalactosamine-analogs, methods of making, and uses of the same. In particular, mono or trivalent N-acetylgalactosamine analogs may be prepared by utilizing a wide variety of linkers containing functional groups. These functionalized N-acetylgalactosamine-analogs may be used in the preparation of targeted delivery of oligonucleotide-based therapeutics.
Claims27
A compound of Formula (I):
- or a pharmaceutically acceptable salt thereof, wherein
- each of R1, R2, and R3 is independently hydrogen, benzyl, or —C(═O)R8;
- R4 is —C(═O)C1-6 alkyl or —C(═O)C1-6 haloalkyl;
- R5 is a hydroxy protecting group;
- R6 is hydrogen, a phosphoramidite moiety, —C(═O)CH2CH2C(═O)R6A, or —P(OR6B)NR6CR6D;
- Y1 is NR7 or *NR7C(═O), the asterisk * indicates that Y1 is connected to L3 through the nitrogen atom of Y1, provided that when Y1 is *NR7C(═O), then L4 is absent;
- Z1 is C(RZ), P(═S), or P(═O), wherein RZ is hydrogen or unsubstituted C1-6 alkyl;
- each of L1, L2, and L3 is independently a bond, —C(═O)—, —C(═S)—, —S(═O)2—, —C(═O)NR9—, —C(═S)NR9—, —C(═O)O—, —C(═S)O—, —NR9C(═O)NR9—, —NR9C(═S)NR9—, —OP(═O)(OH)O—, —OP(═S)(OH)O—, —O—, —S—, —NR9—, optionally substituted C1-10 alkylene, optionally substituted C6-10 arylene, optionally substituted C3-10 cycloalkylene, optionally substituted 5-10 membered hetetroarylene, optionally substituted 5 to 10 membered heterocyclylene, or optionally substituted 2 to 15 membered heteroalkylene wherein one or more carbon atoms are replaced with C(═O), O, S or N, provided that at least one of L1, L2, and L3 is not a bond;
- L4 is optionally substituted C1-8 alkylene;
- each of R7 and R9 is independently hydrogen, unsubstituted C1-6 alkyl, substituted C1-6 alkyl, or an amino protecting group;
- each R8 is independently C1-6 alkyl, C1-6 haloalkyl, or optionally substituted phenyl;
- R6A is —OH, —OR10 or —NR11R12;
- each of R6B, R6C and R6D is independently H, C1-6 haloalkyl, or unsubstituted or substituted C1-6 alkyl;
- R10 is unsubstituted or substituted C1-6 alkyl, or a hydroxy protecting group;
- each of R11 and R12 is independently H, unsubstituted or substituted C1-6 alkyl, or an amino protecting group;
- and
- each of m and n is independently 0, 1, 2 or 3, provided that
- m and n cannot both be 0;
- and
- when -L1-L2-L3- comprise one or more C(═O), Y1 is NR7, Z1 is C(RZ), and m+n=1;
- then RZ is unsubstituted C1-6 alkyl.
18 more elements
Dependencies are inferred from the claim text.